Emma Guttman-Yassky Selected Research

Ligands

12/2023	Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis.
1/2022	C10orf99/GPR15L Regulates Proinflammatory Response of Keratinocytes and Barrier Formation of the Skin.
5/2007	Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emma Guttman-Yassky Research Topics

Disease

152	Atopic Dermatitis (Atopic Eczema) 05/2024 - 11/2008
47	Inflammation (Inflammations) 04/2024 - 03/2011
43	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2023 - 05/2007
26	Alopecia Areata 11/2023 - 11/2015
20	Eczema 01/2024 - 07/2014
19	Pruritus (Itching) 10/2023 - 07/2014
18	Skin Diseases (Skin Disease) 04/2024 - 06/2009
16	Hyperplasia 12/2023 - 06/2009
10	Asthma (Bronchial Asthma) 02/2024 - 07/2014
10	Alopecia (Baldness) 03/2023 - 01/2017
9	Conjunctivitis 05/2024 - 12/2016
9	Infections 05/2024 - 06/2004
8	Atherosclerosis 04/2024 - 10/2015
8	Ichthyosis (Xeroderma) 03/2023 - 01/2017
7	Contact Dermatitis (Eczema, Contact) 02/2019 - 02/2013
6	COVID-19 05/2024 - 01/2021
6	Allergic Contact Dermatitis 02/2019 - 02/2013
5	Headache (Headaches) 05/2024 - 07/2014
5	Vitiligo 09/2023 - 11/2017
5	Neoplasms (Cancer) 01/2023 - 10/2007
4	Respiratory Tract Infections (Respiratory Tract Infection) 05/2024 - 01/2019
4	Chronic Urticaria 01/2023 - 10/2006
4	Injection Site Reaction 01/2023 - 12/2016
4	Nasopharyngitis 01/2023 - 07/2014
4	Hypersensitivity (Allergy) 01/2023 - 10/2017
3	Disease Progression 03/2024 - 09/2014
3	Eosinophilia 01/2024 - 01/2020
3	Acne Vulgaris 06/2023 - 01/2021
3	Dermatitis 01/2022 - 01/2018
2	Hidradenitis Suppurativa 12/2023 - 01/2022
2	Wounds and Injuries (Trauma) 11/2023 - 04/2016
2	Fibrosis (Cirrhosis) 11/2023 - 01/2022
2	Virus Diseases (Viral Diseases) 01/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2023 - 07/2002
2	Blepharitis 01/2023 - 01/2021
2	Rheumatoid Arthritis 01/2023 - 11/2009
2	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

43	Biomarkers (Surrogate Marker)IBA 05/2024 - 09/2011
41	CytokinesIBA 04/2024 - 05/2007
34	dupilumabIBA 01/2023 - 07/2014
20	Interleukin-17 (Interleukin 17)IBA 11/2023 - 11/2008
18	Interleukin-13IBA 04/2024 - 06/2014
17	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2008
12	Janus KinasesIBA 12/2023 - 04/2019
10	RNA (Ribonucleic Acid)IBA 02/2024 - 05/2015
10	Janus Kinase InhibitorsIBA 11/2023 - 01/2019
10	Interleukin-22 (IL-22)IBA 04/2019 - 11/2008
9	InterleukinsIBA 04/2024 - 01/2019
9	Immunoglobulin E (IgE)IBA 01/2024 - 11/2015
8	Monoclonal AntibodiesIBA 04/2024 - 07/2014
8	Keratin-16 (Keratin 16)IBA 12/2023 - 12/2016
8	upadacitinibIBA 12/2023 - 01/2020
8	Interleukin-4 (Interleukin 4)IBA 01/2021 - 10/2007
7	ChemokinesIBA 12/2023 - 05/2007
7	Interleukin-23 (Interleukin 23)IBA 11/2023 - 11/2008
7	SaltsIBA 03/2023 - 01/2019
7	AllergensIBA 01/2023 - 08/2014
7	Filaggrin ProteinsIBA 01/2022 - 01/2017
6	tralokinumabIBA 04/2024 - 01/2019
6	Interleukin-12 (IL 12)IBA 12/2023 - 10/2007
6	Messenger RNA (mRNA)IBA 01/2018 - 11/2008
5	LipidsIBA 01/2023 - 01/2018
5	Immunoglobulin A (IgA)IBA 01/2023 - 01/2020
5	AntigensIBA 01/2022 - 09/2011
5	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2020 - 12/2016
5	Ustekinumab (CNTO 1275)FDA Link 03/2018 - 01/2015
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 05/2007
4	abrocitinibIBA 12/2023 - 12/2020
4	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 10/2006
4	lebrikizumabIBA 06/2023 - 01/2020
4	baricitinibIBA 06/2023 - 04/2019
4	apremilastIBA 03/2023 - 01/2019
4	NickelIBA 01/2023 - 08/2014
4	6-sulfo sialyl Lewis XIBA 01/2023 - 10/2015
4	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2021 - 05/2007
4	SteroidsIBA 01/2021 - 01/2016
4	loricrinIBA 01/2019 - 01/2018
3	LigandsIBA 12/2023 - 05/2007
3	InterferonsIBA 11/2023 - 10/2007
3	Creatine Kinase (Creatine Phosphokinase)IBA 06/2023 - 01/2021
3	secukinumabIBA 03/2023 - 10/2018
3	crisaboroleIBA 01/2023 - 04/2016
3	ElafinIBA 01/2023 - 11/2008
3	ProteomeIBA 01/2023 - 01/2022
3	TYK2 Kinase (Tyrosine Kinase 2)IBA 11/2022 - 01/2021
3	fezakinumabIBA 01/2022 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2017
3	AntibodiesIBA 01/2020 - 06/2011
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 11/2019 - 04/2016
3	Irritants (Vesicants)IBA 02/2019 - 02/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 06/2014
2	OvalbuminIBA 01/2024 - 01/2017
2	S100A12 ProteinIBA 12/2023 - 01/2020
2	difelikefalinIBA 10/2023 - 10/2023
2	Interleukin-33IBA 09/2023 - 04/2019
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2022 - 01/2022
2	Antimicrobial PeptidesIBA 10/2022 - 06/2009

Therapy/Procedure

51	Therapeutics 04/2024 - 03/2011
4	Aftercare (After-Treatment) 01/2023 - 01/2020
2	Biological Therapy 01/2023 - 01/2022